Showing 1 - 10 of 11
Innovation policy involves trading off monopoly output and pricing in the short run in exchange for incentives for …
Persistent link: https://www.econbiz.de/10012481677
Using detailed data on biotechnology in Japan, we find that identifiable collaborations" between particular university star scientists and firms have a large positive impact on firms'" research productivity, increasing the average firm's biotech patents by 34 percent development by 27 percent,...
Persistent link: https://www.econbiz.de/10012472457
This paper applies a rational action/economic sociology approach to the central organizational theory question of whether action is embedded in pre-formed institutions that are relatively cheap in terms of time and energy, or to what extent action becomes embedded in newly constructed...
Persistent link: https://www.econbiz.de/10012473494
Precision medicines - therapies that rely on the use of genetic, epigenetic, and protein biomarkers - create a better match between patients with specific disease subtypes and medications that are more effective for those patients. This heterogeneity in response has implications for the decision...
Persistent link: https://www.econbiz.de/10012453687
This paper explores the economic incentives for medical procedure innovation. Using a proprietary dataset on billing … code applications for emerging medical procedures, we highlight two mechanisms that could hinder innovation. First, the … administrative hurdle of securing permanent, reimbursable billing codes substantially delays innovation diffusion. We find that …
Persistent link: https://www.econbiz.de/10012660115
We follow the careers 1981-2004 of 5401 star scientists listed in ISI HighlyCitedSM as most highly cited by their peers. Their number in a US region or a top-25 science and technology (S&T) country significantly increases the probability of firm entry in the S&T field in which they are working....
Persistent link: https://www.econbiz.de/10012465099
agenda to integrate major research streams treating innovation as an object of economic analysis into our standard models … outcome. The totality of possible outcomes drives the national innovation system and the returns to a particular successful … required to motivate investment attempting to turn them into an innovation. The alternative to a valuable proprietary …
Persistent link: https://www.econbiz.de/10012466574
Pharmaceutical innovation policy involves managing a tradeoff between high prices for new products in the short … pharmaceuticals, suggesting low(er) price markets may have different dynamics with respect to innovation policy …
Persistent link: https://www.econbiz.de/10012533304
Research on intellectual property has focused on formal legally recorded rights that we call deeded, most often measured by granted patents. Meanwhile, other "defacto" IP (mainly purposive secrecy and natural excludability) has become more important because of the increasing closeness of...
Persistent link: https://www.econbiz.de/10012458417
Persistent link: https://www.econbiz.de/10013464979